KBRA Releases Research – KBRA Reiterates Confidence in U.S.’s AAA Rating
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report to reiterate its confidence in the U.S.’s AAA credit…
News
Enviva Reports 2Q 2023 Results and Provides Progress Update on Cost and Productivity Improvement Initiatives
BETHESDA, Md.–(BUSINESS WIRE)–Enviva Inc. (NYSE: EVA) (“Enviva,” the “Company,” “we,” “us,” or “our”) today released…
Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings
Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment…
Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings
Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment…
Vaxil Provides Update on Research Activities and Management Changes
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company“) (TSX…
Vaxil Provides Update on Research Activities and Management Changes
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company“) (TSX…
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results
Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton…
BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023
CAMBRIDGE, Mass. and NESS ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
Digitate’s New Generative AI Capability Unlocks Innovation and Delivers Greater Agility Across Enterprises
Digitate offers advanced, generative AI-driven use cases to scale automation and maximize user experience SANTA…
Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023
ALPHARETTA, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company…
Generation Bio Reports Second Quarter 2023 Financial Results
Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025 CAMBRIDGE,…
Molecular Templates Announces Executive Leadership Changes
Dr. Gabriela Gruia to assume the role of interim Chief Medical Officer Jason Kim to…
Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a…
Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results
SEATTLE, Aug. 02, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
Webcast Scheduled for Wednesday, August 9, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE,…
Y-mAbs to Participate at Upcoming Investor Conferences
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Roivant Announces Redemption of Outstanding Warrants
BASEL, Switzerland and LONDON and NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — Roivant (Nasdaq:…
Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA),…
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
Presented Long-Term Data for an Allogeneic CD19 CAR T Product Candidate in Relapsed/Refractory Large B…